EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 3.0

The Bonferroni Paradox: When Secondary Analyses are Held to a Stricter Standard Than the Primary Endpoint [Letter]

Yanan Pu, Dongnan Hou, Jiayuan Niu

Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-3

DOI: 10.2147/dddt.s633921 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Yanan Pu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We read with great interest the randomized controlled trial by Han et al comparing remimazolam with propofol for anesthesia in patients undergoing renal allograft transplantation, published in Drug Design, Development and Therapy 1 The study addresses an important clinical question, and the pharmacokinetic substudy is particularly welcome.However, we have identified several methodological concerns that may affect the interpretation of the findings and warrant clarification from the authors. Inadequate Handling of Repeated-Measures Hemodynamic Data and an Unintended Statistical Double StandardThe authors measured mean arterial pressure (MAP) and heart rate (HR) at 8 predetermined time points and compared these at each time point using two-sample t-tests, applying a Bonferroni-corrected threshold of 0.003125 (0.05/16).While we commend the authors for attempting to account for multiplicity, this approach presents a critical logical inconsistency.The primary endpoint -incidence of hypotension during induction (P = 0.010) -was not subjected to any multiplicity correction, whereas the secondary hemodynamic comparisons were held to a far stricter standard (P < 0.003125).Had the primary endpoint been evaluated against this same Bonferroni threshold, it would not have achieved statistical significance, fundamentally undermining the study's central conclusion.This double standard, wherein secondary endpoints face a more stringent evidentiary bar than the primary endpoint, represents a reversal of standard statistical prioritization and severely weakens the interpretability of the findings.Beyond this logical paradox, the Bonferroni correction itself is fundamentally inappropriate for correlated repeated measurements.The correction assumes independence among comparisons, yet repeated hemodynamic measurements from the same patient are inherently correlated, rendering the method excessively conservative and markedly inflating the risk of Type II error.Analyzing longitudinal data through a series of pairwise t-tests further fails to exploit the withinsubject correlation structure and cannot model time-by-group interaction effects.Repeated-measures ANOVA or linear mixed-effects models would have been the statistically appropriate methods, as they account for intra-individual correlation, handle missing data more robustly, and provide a unified test of the treatment effect across the entire perioperative trajectory without requiring such untenable ad hoc corrections.We would welcome the authors' rationale for this analytical choice.

Autor:innen und Institutionen

  • Department of Anesthesiology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China.

Zitieren

APA

Pu, Y., Hou, D., & Niu, J. (2026). The Bonferroni Paradox: When Secondary Analyses are Held to a Stricter Standard Than the Primary Endpoint [Letter]. Drug Design, Development and Therapy, Volume 20, 1-3. https://doi.org/10.2147/dddt.s633921

Vancouver

Pu Y, Hou D, Niu J. The Bonferroni Paradox: When Secondary Analyses are Held to a Stricter Standard Than the Primary Endpoint [Letter]. Drug Design, Development and Therapy. 2026;Volume 20:1-3. doi:10.2147/dddt.s633921

BibTeX
@article{Pu2026,
  author = {Pu, Yanan and Hou, Dongnan and Niu, Jiayuan},
  title = {The Bonferroni Paradox: When Secondary Analyses are Held to a Stricter Standard Than the Primary Endpoint [Letter]},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--3},
  doi = {10.2147/dddt.s633921}
}
Kostenlos starten →